• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病的基因工程小鼠模型。

Genetically engineered mouse models of Parkinson's disease.

机构信息

Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

出版信息

Brain Res Bull. 2012 May 1;88(1):13-32. doi: 10.1016/j.brainresbull.2011.07.019. Epub 2011 Aug 3.

DOI:10.1016/j.brainresbull.2011.07.019
PMID:21839151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3244549/
Abstract

Parkinson's disease (PD) is the most common neurodegenerative movement disorder, affecting more than 1% of the population over age 60. The most common feature of PD is a resting tremor, though there are many systemic neurological effects, such as incontinence and sleep disorders. PD is histopathologically identified by the presence of Lewy bodies (LB), proteinaceous inclusions constituted primarily by α-synuclein. To date, there is no effective treatment to slow or stop disease progression. To help understand disease pathogenesis and identify potential therapeutic targets, many genetic mouse models have been developed. By far the most common of these models are the wildtype and mutant α-synuclein transgenic mice, because α-synuclein was the first protein shown to have a direct effect on PD pathogenesis and progression. There are many other gene-disrupted or -mutated models currently available, which are based on genetic anomalies identified in the human disease. In addition, there are also models which examine genes that may contribute to disease onset or progression but currently have no identified causative PD mutations. These genes are part of signaling pathways important for maintaining neuronal function in the nigrostriatal pathway. This review will summarize the most commonly used of the genetic mouse models currently available for PD research. We will examine how these models have expanded our understanding of PD pathogenesis and progression, as well as aided in identification of potential therapeutic targets in this disorder.

摘要

帕金森病(PD)是最常见的神经退行性运动障碍,影响超过 60 岁的人群的 1%以上。PD 的最常见特征是静止性震颤,但也有许多全身性神经系统影响,如失禁和睡眠障碍。PD 在组织病理学上通过Lewy 体(LB)的存在来识别,LB 是由α-突触核蛋白组成的蛋白包涵体。迄今为止,尚无有效的治疗方法可以减缓或阻止疾病进展。为了帮助理解疾病发病机制并确定潜在的治疗靶点,已经开发了许多遗传小鼠模型。到目前为止,这些模型中最常见的是野生型和突变型α-突触核蛋白转基因小鼠,因为α-突触核蛋白是第一个被证明对 PD 发病机制和进展有直接影响的蛋白质。目前还有许多其他基因缺失或突变的模型,这些模型基于在人类疾病中发现的遗传异常。此外,还有一些模型研究可能导致疾病发作或进展的基因,但目前没有确定的导致 PD 的突变。这些基因是对黑质纹状体通路中维持神经元功能很重要的信号通路的一部分。这篇综述将总结目前可用于 PD 研究的最常用的遗传小鼠模型。我们将研究这些模型如何扩展我们对 PD 发病机制和进展的理解,并有助于确定该疾病的潜在治疗靶点。

相似文献

1
Genetically engineered mouse models of Parkinson's disease.帕金森病的基因工程小鼠模型。
Brain Res Bull. 2012 May 1;88(1):13-32. doi: 10.1016/j.brainresbull.2011.07.019. Epub 2011 Aug 3.
2
How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?重组腺相关病毒-α-突触核蛋白和丝状α-突触核蛋白模型如何促进我们对帕金森病的理解?
J Neurochem. 2016 Oct;139 Suppl 1(Suppl 1):131-155. doi: 10.1111/jnc.13627. Epub 2016 May 4.
3
α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.α-突触核蛋白的单拷贝转基因表达增加了对帕金森病遗传模型中应激的敏感性并加速了神经元的丢失。
Exp Neurol. 2018 Dec;310:58-69. doi: 10.1016/j.expneurol.2018.09.001. Epub 2018 Sep 5.
4
α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.α-突触核蛋白 BAC 转基因小鼠表现出类似 RBD 的行为和嗅觉减退:一种前驱性帕金森病模型。
Brain. 2020 Jan 1;143(1):249-265. doi: 10.1093/brain/awz380.
5
New Developments in Genetic rat models of Parkinson's Disease.帕金森病基因大鼠模型的新进展。
Mov Disord. 2018 May;33(5):717-729. doi: 10.1002/mds.27296. Epub 2018 Feb 8.
6
The role of age-associated alpha-synuclein aggregation in a conditional transgenic mouse model of Parkinson's disease: Implications for Lewy body formation.年龄相关的α-突触核蛋白聚集在帕金森病条件性转基因小鼠模型中的作用:对路易体形成的影响。
J Neurochem. 2024 Jul;168(7):1215-1236. doi: 10.1111/jnc.16122. Epub 2024 May 1.
7
Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.神经炎症和α-突触核蛋白功能障碍相互促进,导致帕金森病小鼠模型中神经退行性变的慢性进展。
Environ Health Perspect. 2011 Jun;119(6):807-14. doi: 10.1289/ehp.1003013. Epub 2011 Jan 18.
8
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's Disease.组织因子及其在帕金森病中的脑脊液蛋白谱。
J Parkinsons Dis. 2024;14(7):1405-1416. doi: 10.3233/JPD-240115.
9
Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease.金属硫蛋白在帕金森病基因工程小鼠模型中的神经保护作用
Brain Res Mol Brain Res. 2005 Mar 24;134(1):67-75. doi: 10.1016/j.molbrainres.2004.09.011.
10
Complement and Coagulation Cascades are Potentially Involved in Dopaminergic Neurodegeneration in α-Synuclein-Based Mouse Models of Parkinson's Disease.补体和凝血级联反应可能参与了基于α-突触核蛋白的帕金森病小鼠模型中的多巴胺能神经退行性变。
J Proteome Res. 2021 Jul 2;20(7):3428-3443. doi: 10.1021/acs.jproteome.0c01002. Epub 2021 Jun 1.

引用本文的文献

1
Rock inhibitors in Alzheimer's disease.阿尔茨海默病中的岩石抑制剂。 (不过这里“rock inhibitors”表述不太准确,可能是“tau inhibitors”之类的,按给定文本翻译是这样)
Front Aging. 2025 Mar 20;6:1547883. doi: 10.3389/fragi.2025.1547883. eCollection 2025.
2
Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson's disease in rodent brains.非侵入性系统性病毒传递人类α-突触核蛋白在啮齿类动物大脑中模拟帕金森病的选择性和进行性神经病理学。
Mol Neurodegener. 2023 Nov 27;18(1):91. doi: 10.1186/s13024-023-00683-8.
3
α-Synuclein Pathology and Reduced Neurogenesis in the Olfactory System Affect Olfaction in a Mouse Model of Parkinson's Disease.α-突触核蛋白病理学和嗅觉系统中的神经发生减少会影响帕金森病小鼠模型的嗅觉。
J Neurosci. 2023 Feb 8;43(6):1051-1071. doi: 10.1523/JNEUROSCI.1526-22.2022. Epub 2023 Jan 3.
4
Intermittent and periodic fasting, longevity and disease.间歇性禁食和周期性禁食、长寿与疾病。
Nat Aging. 2021 Jan;1(1):47-59. doi: 10.1038/s43587-020-00013-3. Epub 2021 Jan 14.
5
Mechanistic Insights Expatiating the Redox-Active-Metal-Mediated Neuronal Degeneration in Parkinson's Disease.阐释帕金森病中氧化还原活性金属介导神经元变性的机制见解。
Int J Mol Sci. 2022 Jan 8;23(2):678. doi: 10.3390/ijms23020678.
6
Sleep and circadian rhythms in Parkinson's disease and preclinical models.帕金森病及临床前模型中的睡眠与昼夜节律。
Mol Neurodegener. 2022 Jan 9;17(1):2. doi: 10.1186/s13024-021-00504-w.
7
Animal models of Parkinson's disease: a guide to selecting the optimal model for your research.帕金森病动物模型:为您的研究选择最佳模型指南
Neuronal Signal. 2021 Dec 8;5(4):NS20210026. doi: 10.1042/NS20210026. eCollection 2021 Dec.
8
Resveratrol in Rodent Models of Parkinson's Disease: A Systematic Review of Experimental Studies.白藜芦醇在帕金森病啮齿动物模型中的研究:实验性研究的系统评价
Front Pharmacol. 2021 Apr 22;12:644219. doi: 10.3389/fphar.2021.644219. eCollection 2021.
9
Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson's disease.肝脏中 alpha-突触核蛋白的积累,可能在清除帕金森病相关脑病理中的作用。
Acta Neuropathol Commun. 2021 Mar 20;9(1):46. doi: 10.1186/s40478-021-01136-3.
10
The Path to Progress Preclinical Studies of Age-Related Neurodegenerative Diseases: A Perspective on Rodent and hiPSC-Derived Models.衰老相关神经退行性疾病的临床前研究进展:啮齿动物和 hiPSC 衍生模型的视角。
Mol Ther. 2021 Mar 3;29(3):949-972. doi: 10.1016/j.ymthe.2021.01.001. Epub 2021 Jan 9.

本文引用的文献

1
The PINK1/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons.PINK1/Parkin 通路调节哺乳动物海马体和多巴胺能神经元中线粒体的动态和功能。
Hum Mol Genet. 2011 Aug 15;20(16):3227-40. doi: 10.1093/hmg/ddr235. Epub 2011 May 25.
2
Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease.帕金森病非运动症状的神经病理学和神经化学。
Parkinsons Dis. 2011 Feb 17;2011:708404. doi: 10.4061/2011/708404.
3
Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease.帕金森病患者嗅觉功能障碍与大脑代谢的相关性研究。
Mov Disord. 2011 Mar;26(4):621-8. doi: 10.1002/mds.23602. Epub 2011 Jan 31.
4
Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria.帕金森病的遗传小鼠模型显示神经胶质细胞线粒体严重病变。
Hum Mol Genet. 2011 Mar 15;20(6):1197-211. doi: 10.1093/hmg/ddq564. Epub 2011 Jan 6.
5
Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.路易体病和α-突触核蛋白病转基因模型中 mGluR5 表达和信号转导的改变——对兴奋性毒性的影响。
PLoS One. 2010 Nov 16;5(11):e14020. doi: 10.1371/journal.pone.0014020.
6
Mitochondrial α-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo.线粒体α-突触核蛋白积累损害多巴胺能神经元中的复合物 I 功能,并导致体内噬线粒体增加。
Neurosci Lett. 2010 Dec 17;486(3):235-9. doi: 10.1016/j.neulet.2010.09.061. Epub 2010 Sep 29.
7
Pathogenic lysosomal depletion in Parkinson's disease.帕金森病中的致病溶酶体耗竭。
J Neurosci. 2010 Sep 15;30(37):12535-44. doi: 10.1523/JNEUROSCI.1920-10.2010.
8
Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics.帕金森病相关基因 DJ-1 的缺失会扰乱线粒体动力学。
Hum Mol Genet. 2010 Oct 1;19(19):3734-46. doi: 10.1093/hmg/ddq288. Epub 2010 Jul 16.
9
A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice.A53T-α-突触核蛋白过表达损害老年小鼠的多巴胺信号传递和纹状体突触可塑性。
PLoS One. 2010 Jul 7;5(7):e11464. doi: 10.1371/journal.pone.0011464.
10
Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1.α-突触核蛋白通过诱导基质金属蛋白酶的表达和随后激活蛋白酶激活受体-1来激活小胶质细胞。
J Immunol. 2010 Jul 1;185(1):615-23. doi: 10.4049/jimmunol.0903480. Epub 2010 May 28.